ADXS - Ayala Pharmaceuticals, Inc.
0.25
0.250 100.000%
Share volume: 0
Last Updated: 01-05-2022
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
25%
Profitability
0%
Dept financing
40%
Liquidity
55%
Performance
40%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2019 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.08%
Return on assets
-38.11%
Return on sales
-63810.75%
Return on invested capital
-19.38%
Total debt ratio
57.07%
Debt ratio change over timeo
-1.2%
Current Ratio
6.86%
Quick Ratio
8.14%
Cash Position Ratio
6.24%
Short-term ratios 31-Dec-2022 - 31-Dec-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-70.55%
Return on sales
-195506.94%
Return on invested capital
0%
Total debt ratio
145.57%
Debt ratio change over timeo
0%
Current Ratio
0.96%
Quick Ratio
0%
Cash Position Ratio
0.75%
Last quarter ratios 31-Dec-2023
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-52.96%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
247.28%
Debt ratio change over time
0%
Current Ratio
0.3%
Quick Ratio
0%
Cash Position Ratio
0.2%
Performance ratios (change over 4 years) 31-Dec-2019 - 31-Dec-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-83.25%
Return on assets
-86.37%
Return on sales
24144.83%
Return on invested capital
-53.79%
Total debt ratio
-119.62%
Debt ratio change over time
-1.2%
Current Ratio
-8.98%
Quick Ratio
-8.98%
Cash Position Ratio
-8.19%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ADXS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.08% | 20.89% | 8.28% | 6.35% |
| Return on assets | -38.11% | 4.1% | 3.2% | 2.49% |
| Return on sales | -63810.75% | 27.46% | 25.3% | 29.25% |
| Return on invested capital | -19.38% | 8.72% | 7.96% | 3.44% |
| Profitability | 0% | 98% | 74% | 58% |
| Total debt ratio | 57.07% | 83.67% | 60.1% | 91.31% |
| Debt ratio change over time | -1.2% | -9.8% | -33.64% | 406.6% |
| Dept financing | 16% | 23% | 16% | 50% |
| Current Ratio | 0.96% | 1.1% | 1.14% | 0.92% |
| Quick Ratio | 0% | 0.86% | 0.9% | 0.8% |
| Cash Position Ratio | 0.75% | 0.15% | 0.48% | 0.31% |
| Liquididy | 75% | 8% | 10% | 8% |
| Short-term ratios | ADXS | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 9.15% | 14.43% | 0% |
| Return on assets | -70.55% | 4.22% | 3.31% | 1.47% |
| Return on sales | -195506.94% | 27.83% | 25.21% | 23.48% |
| Return on invested capital | 0% | 6.63% | 14.96% | 0% |
| Profitability | 0% | 77% | 92% | 30% |
| Total debt ratio | 145.57% | 80.64% | 60.17% | 91.02% |
| Debt ratio change over time | 0% | -57.9% | -209.85% | 0% |
| Dept financing | 50% | 14% | 10% | 16% |
| Current Ratio | 0.96% | 1.1% | 1.14% | 0.92% |
| Quick Ratio | 0% | 0.86% | 0.9% | 0.8% |
| Cash Position Ratio | 0.75% | 0.15% | 0.48% | 0.31% |
| Liquididy | 46% | 53% | 66% | 53% |